Landmark Health (“Landmark” or the “Company”), a leading provider of in-home, risk-based medical care, is pleased to announce that General Atlantic, a leading global growth equity firm, has made a strategic investment in the Company.
Benevity, Inc., a global provider of corporate social responsibility and employee engagement software, announced today that General Atlantic, a leading global growth equity firm, has made a strategic investment in the company. This investment comes as Benevity achieves record client growth with its workplace giving, volunteering and community investment technology, which revitalizes traditional corporate philanthropy by helping businesses infuse purpose and meaning into their corporate cultures and consumer-facing brands. In its next phase of growth, Benevity expects to continue to innovate its products and services, expand its charitable network of almost two million charities and nonprofits, and scale its operations to maximize efficiencies and reach new markets.
Jonathan Korngold, Managing Director and Global Head of General Atlantic's Financial Services Sector, was named the top investor (and #2 overall) to Institutional Investor's "Fintech Finance 40," a list of top players in fintech investing. He was named #1 to Institutional Investor’s “Fintech Finance 35” last year.
Alkami Technology Inc., a leading provider of digital banking solutions to credit unions and banks, announced today that General Atlantic, a leading global growth equity firm, has made a strategic investment in the company. General Atlantic will be joining existing investors S3 Ventures, Argonaut Private Equity, and a number of other strategic fintech investors in Alkami’s next stage of innovation, growth, and expansion.
Ginkgo Bioworks, the organism company, today announced the opening of Bioworks3–Ginkgo’s third foundry for prototyping and scaling engineered organisms. This expansion is supported by $275 million in a Series D round with participation from all previous investors, including Viking Global, Y Combinator’s Continuity Fund, and Cascade Investment, the private investment vehicle of William H. Gates III, as well as new investors, including General Atlantic, a leading global growth equity firm. This brings the company’s total funding to $429 million. The new foundry will bring the power of biology to new markets including pharmaceuticals, agriculture and textiles, and accelerate the timeline for bringing current projects to commercial scale.
General Atlantic, a leading global growth equity firm, announced today that Cathy Beaudoin, former President of Amazon Fashion, has joined General Atlantic as a Special Advisor. Ms. Beaudoin will work closely with General Atlantic’s Global Retail & Consumer team and other sector investment teams to identify investment opportunities and support the firm’s existing portfolio of companies.
Sam Lerer, Vice President on General Atlantic's Internet and Technology team, was named to Forbes’ “30 Under 30” Venture Capital List, for investing in the next great technology companies. The list was selected by Forbes’ editorial team and a panel of industry judges to honor men and women under the age of 30 who provide funding and support to leading startups. Sam joined General Atlantic in 2013 to focus on investments in the Internet & Technology sector.
Andrew Ferrer, Principal in General Atlantic’s New York office, was named to WWD’s 40 Under 40 List. The list was selected by WWD’s editorial team to honor men and women under the age of 40 with innovative approaches to business in design, investment, or marketing. Andrew joined General Atlantic in 2014 to focus on investments in the Retail & Consumer sector.
General Atlantic, a leading global growth equity firm, announced today that Andy Slavitt, former Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) and the former Group Executive Vice President at Optum, will become a Special Advisor to General Atlantic. He will bring a special focus on healthcare investments in underserved populations.
General Atlantic, a leading global growth equity firm, announced today that Michelle Dipp, M.D., Ph.D., Co-Founder and former General Partner of Longwood Fund, has joined General Atlantic as a Managing Director in the firm’s New York office. Dr. Dipp will be a senior member of the firm’s Global Healthcare team and will focus on biopharma and life sciences investments.
Sonendo, Inc., a leading dental technology company, announced today that General Atlantic, a leading global growth equity firm, has made a strategic investment in the company. General Atlantic will be joining existing investors Fjord Ventures, OrbiMed Advisors LLC, Meritech Capital Partners, CVF LLC, and NeoMed to lead the company’s latest fundraising round valued at $50 million. In its next phase of growth, Sonendo plans to accelerate ongoing commercialization efforts and further expand and diversify its current product portfolio.